Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Incyte Corporation and Bristol-Myers Squibb have formed a clinical trial collaboration to evaluate the safety, tolerability, and preliminary efficacy of a combination regimen of Bristol-Myers Squibb's investigational PD-1 immune checkpoint...

Pfizer issued a statement on May 26, 2014 to announce that it does not intend to make an offer for AstraZeneca. Pfizer made the announcement in line with UK takeover rules  which required the company to either make a formal offer to...

In ongoing litigation over the safety of its diabetes drug Actos (pioglitazone HCl), Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Bertha Triana...

Celgene Corporation has made several changes to its senior management team, effective August 1, 2014.  Mark Alles, currently head of the company's hematology and oncology franchise, will become president and chief operating officer....

AbbVie has been granted orphan drug designation by FDA for Humira (adalimumab) for treating non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases...

The specialty pharmaceutical company Hemispherx Biopharma, Inc. has signed a preliminary stage agreement with GP Pharma, a pharmaceutical company headquartered in Barcelona, Spain, to manufacture Ampligen, an investigational  RNA nucleic...